Habib J. Dable, CEO and President at ACCELERON PHARMA INC (XLRN), sold 8,300 shares at $120.52 ($1.0M) on 2021-01-05, disclosed to the SEC on 2021-01-06.
Open-market sale of $1.0M XLRN by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $124.31 | 3,278 | $407K | 40.1% |
| 2 | $120.52 | 2,500 | $301K | 29.6% |
| 3 | $121.55 | 900 | $109K | 10.8% |
| 4 | $122.46 | 764 | $94K | 9.2% |
| 5 | $122.46 | 764 | $94K | 9.2% |
| 6 | $122.55 | 94 |
| $12K |
| 1.1% |
| Total | $122.51 avg | 8,300 | $1.0M | 100% |
| Filing → |
| XLRN | SELL | 2020-01-03 | $377K | — | Filing → |
| XLRN | SELL | 2019-09-10 | $493K | — | Filing → |
| XLRN | SELL | 2019-04-11 | $654K | — | Filing → |